Association of steroid use with survival in solid tumours-Reference-Cited by-同舟云学术

Association of steroid use with survival in solid tumours

Published:2020-12 Issue: Volume:141 Page:105-114
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Petrelli Fausto^ORCID,Bukovec Roberta,Perego Gianluca^ORCID,Luisa Roncari,Luciani Andrea,Zaniboni Alberto,Ghidini Antonio^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference8 articles.

1. Differential glucocorticoid-dependent regulation and function of the ERRFI1 gene in triple-negative breast cancer;Mojica;Endocrinology,2020

2. Glucocorticoids promote breast cancer metastasis;Obradović;Nature,2019

3. Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy;Giles;J Immunother Cancer,2018

4. Wells GA O'connell D. BS. The Newcastle-Scale for assessing the quality of nonrandomized studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute.

5. Association of steroids use with survival in patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis;Petrelli;Cancers (Basel),2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancer;Clinical Rheumatology;2024-09-04

2. Why do patients with cancer die?;Nature Reviews Cancer;2024-06-19

3. Explainable Machine Learning Model to Predict Overall Survival in Patients Treated With Palliative Radiotherapy for Bone Metastases;JCO Clinical Cancer Informatics;2024-06

4. Utilization of Biologic Disease‐Modifying Antirheumatic Therapy in Patients With Rheumatoid Arthritis and Recently Diagnosed Breast Cancer;Arthritis Care & Research;2024-03-06

5. Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study);JCO Global Oncology;2024-02